{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:22:29Z","timestamp":1792027349164,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejps.2021.105818","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T02:19:18Z","timestamp":1616552358000},"page":"105818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Population pharmacokinetics and individual analysis of daptomycin in kidney transplant recipients"],"prefix":"10.1016","volume":"162","author":[{"given":"Yan","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liefeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunchun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.105818_bib0001","first-page":"95","article-title":"Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens","volume":"3","author":"Beiras-Fernandez","year":"2010","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejps.2021.105818_bib0002","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2021.105818_bib0003","first-page":"e51","article-title":"Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance","volume":"2","author":"Byon","year":"2013","journal-title":"CPT: Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105818_bib0004","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s10096-012-1560-7","article-title":"Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries","volume":"31","author":"Canut","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejps.2021.105818_bib0005","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/jac\/dkx140","article-title":"Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies","volume":"72","author":"Cojutti","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2021.105818_bib0006","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s40265-016-0610-3","article-title":"Daptomycin pharmacokinetics and pharmacodynamics in septic and critically ill patients","volume":"76","author":"D\u2019Avolio","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2021.105818_bib0007","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","article-title":"Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects","volume":"47","author":"Dvorchik","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2021.105818_bib0008","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ckj\/sfs076","article-title":"Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient","volume":"5","author":"Eden","year":"2012","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.ejps.2021.105818_bib0009","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/clinids\/20.5.1126","article-title":"Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection","volume":"20","author":"Edmond","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2021.105818_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkx349","article-title":"Daptomycin","volume":"73","author":"Heidary","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2021.105818_bib0011","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/jps.23574","article-title":"A pharmacokinetic standard for babies and adults","volume":"102","author":"Holford","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105818_bib0012","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11095-007-9361-x","article-title":"Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method","volume":"24","author":"Hooker","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2021.105818_bib0013","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CMR.00030-13","article-title":"A current perspective on daptomycin for the clinical microbiologist","volume":"26","author":"Humphries","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2021.105818_bib0014","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/tid.12232","article-title":"Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation","volume":"16","author":"Len","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.ejps.2021.105818_bib0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2021.105818_bib0016","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/AAC.01604-15","article-title":"Observed antagonistic effect of linezolid on daptomycin or vancomycin activity against biofilm-forming methicillin-resistant staphylococcus aureus in an in vitro pharmacodynamic model","volume":"59","author":"Luther","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2021.105818_bib0017","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/aor.12473","article-title":"Prognostic significance of 1-year serum albumin levels within the normal range after kidney transplantation","volume":"39","author":"Oh","year":"2015","journal-title":"Artif. Organs"},{"key":"10.1016\/j.ejps.2021.105818_bib0018","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jcpt.12200","article-title":"Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review","volume":"39","author":"Polso","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejps.2021.105818_bib0019","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/FTD.0000000000000196","article-title":"Therapeutic drug monitoring of daptomycin: a retrospective monocentric analysis","volume":"37","author":"Reiber","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2021.105818_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1021\/acsinfecdis.7b00015","article-title":"Plasma protein binding structure-activity relationships related to the N-terminus of daptomycin","volume":"3","author":"Schneider","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejps.2021.105818_bib0021","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jiac.2019.08.017","article-title":"Pharmacokinetics and pharmacodynamics of daptomycin in a clinical setting","volume":"26","author":"Tsukada","year":"2020","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ejps.2021.105818_bib0022","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s40262-017-0533-5","article-title":"Population pharmacokinetics and Bayesian estimators for refined dose adjustment of a new tacrolimus formulation in kidney and liver transplant patients","volume":"56","author":"Woillard","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2021.105818_bib0023","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/jac\/dkaa028","article-title":"Population pharmacokinetics and dosing considerations of daptomycin in critically ill patients undergoing continuous renal replacement therapy","volume":"75","author":"Xie","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2021.105818_bib0024","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/bcp.13131","article-title":"Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy","volume":"83","author":"Xu","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105818_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2017.07.008","article-title":"An animal model of co-existing sarcopenia and osteoporotic fracture in senescence accelerated mouse prone 8 (SAMP8)","volume":"97","author":"Zhang","year":"2017","journal-title":"Exp. Gerontol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:59:43Z","timestamp":1760529583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":25,"alternative-id":["S0928098721001202"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105818","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics and individual analysis of daptomycin in kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105818"}}